Skip to main content
Publications
Razavi P, Ahmed M, Roush A, Parikh R , Hitchens A , Shen S, Safonov A, Jhaveri K, Robson M, Peacock N, Ma Y, Santarsiero E, Ganapathy V, Shah R, Amaefule A, Lteif A, Blakely J. Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in the US . J Clin Oncol. 2024 May;42(Suppl 16):e12533.
Josa-Cullere A, Basagana X, Koch S, Arbillaga-Etxarri A, Balcells E, Bosch de Basea M, Celorrio N, Foraster M , Rodriguez-Roisin R, Marin A, Peralta GP, Rodriguez-Chiaradia DA, Simonet P, Toran-Monserrat P, Vall-Casas P, Garcia-Aymerich J. Short-term effects of air pollution and weather on physical activity in patients with chronic obstructive pulmonary disease (COPD) . Environ Res. 2024 Apr;247:118195. doi: 10.1016/j.envres.2024.118195.
Persson Waye K, Love J, Lercher P, Dzhambov AM, Klatte M, Schreckenberg D, Belke C, Leist L, Ristovska G, Jeram S, Kanninen KM, Selander J, Arat A, Lachmann T, Clark C, Botteldooren D, White K, Julvez J, Foraster M , Kaprio J, Bolte G, Psyllidis A, Gulliver J, Boshuizen H, Bozzon A, Fels J, Hornikx M, van den Hazel P, Weber M, Brambilla M, Braat-Eggen E, van Kamp I, Vincens N, Equal-life Scientific Team. Adopting a child perspective for exposome research on mental health and cognitive development - conceptualisation and opportunities . Environ Res. 2023 Dec 15;239 (Pt 1):117279. doi: 10.1016/j.envres.2023.117279
Moehler M, Xiao H, Blum SI, Elimova E, Cella D, Shitara K, Ajani JA, Janjigian YY, Garrido M, Shen L, Yamaguchi K, Liu T, Schenker M, Kowalyszyn R, Bragagnoli AC, Bruges R, Montesarchio V, Pazo-Cid R, Hunter S, Davenport E , Wang J , Kondo K, Li M, Wyrwicz L. Health-Related quality of life with nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric/gastroesophageal junction cancer or esophageal adenocarcinoma from CheckMate 649 . J Clin Oncol. 2023 Dec 10;41(35):5388-99. doi: 10.1200/JCO.23.00170
Dzhambov AM, Lercher P, Vincens N, Persson Waye K, Klatte M, Leist L, Lachmann T, Schreckenberg D, Belke C, Ristovska G, Kanninen KM, Botteldooren D, Van Renterghem T, Jeram S, Selander J, Arat A, White K, Julvez J, Clark C, Foraster M , van Kamp I. Protective effect of restorative possibilities on cognitive function and mental health in children and adolescents: a scoping review including the role of physical activity . Environ Res. 2023 Sep 15;233:116452. doi: 10.1016/j.envres.2023.116452
Balboni E, Filippini T, Rothman KJ , Costanzini S, Bellino S, Pezzotti P, Brusaferro S, Ferrari F, Orsini N, Teggi S, Vinceti M. The influence of meteorological factors on COVID-19 spread in Italy during the first and second wave . Environ Res. 2023 Jul 1;228:115796. doi: 10.1016/j.envres.2023.115796
Edwards T , Norcross L , Fine J, Martin S , Coulouvrat C, Spears P, Herold CI, Ferrari G, Onwudiwe N. Side effects and impacts of extended adjuvant endocrine therapy: a qualitative study among women with HR+/HER2- breast cancer . Poster presented at the 2023 ASCO Annual Meeting; June 2, 2023. Chicago, IL. [abstract] J Clin Oncol. 2023 Jun; 41(Suppl 16):e12509. doi: 10.1200/JCO.2023.41.16_suppl.e12509
Grivas P, Barata PC, Moon H, Hutson TE, Gupta S, Sternberg CN, Dave V, Downey C , Shillington AC, Devgan G, Kirker M, Thakkar S, Katzenstein HM, Bhanegaonkar A, Liu F, Brown J, Sonpavde GP. Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II) . Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Francisco, CA. [abstract] J Clin Oncol. 2023 Feb 1; 41(Suppl 4). doi: 10.1200/JCO.2023.41.6_suppl.465
Furqan M, Karanth S , Goyal RK , Shih Y, Cai B, Rombi J , Davis KL , Caro N, Saliba TR. Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14) . Poster presented at the 2023 ASCO Annual Meeting; June 2, 2023. Chicago, IL. [abstract] J Clin Oncol. 2023; 4((Suppl 16):e21112.
Koreny M, Arbillaga-Etxarri A, Bosch de Basea M, Foraster M , Carsin AE , Cirach M, Gimeno-Santos E, Barberan-Garcia A, Nieuwenhuijsen M, Vall-Casas P, Rodriguez-Roisin R, Garcia-Aymerich J. Urban environment and physical activity and capacity in patients with chronic obstructive pulmonary disease . Environ Res. 2022 Nov;214(Pt 2):113956. doi: 10.1016/j.envres.2022.113956
Stapleton A, Casas M, Garcia J, Garcia R , Sunyer J, Guerra S, Abellan A , Lavi I, Dobano C, Vidal M, Gascon M. Associations between pre- and postnatal exposure to air pollution and lung health in children and assessment of CC16 as a potential mediator . Environ Res. 2022 Mar;204(Pt A):111900. doi: 10.1016/j.envres.2021.111900
Moitra S, Foraster M , Abrillaga-Etxarri A, Marin A, Barberan-Garcia A, Rodriguez-Chiaradia DA, Balcells E, Koreny M, Toran-Monserrat P, Vall-Casas P, Rodriguez-Roisin R, Garcia-Aymerich J. Roles of the physical environment in health-related quality of life in patients with chronic obstructive pulmonary disease . Environ Res. 2022 Jan;203:111828. doi: 10.1016/j.envres.2021.111828
Moitra S, Foraster M , Arbillaga-Etxarri A, Marin A, Barberan-Garcia A, Rodriguez-Roisin R, Balcells E, Koreny M, Toran-Monserrat P, Vall-Casas P, Rodriguez-Chiaradia DA, Garcia-Aymerich J. Roles of the physical environment in health-related quality of life in with chronic obstructive disease . Environ Res. 2022 Jan;203:111828. doi: 10.1016/j.envres.2021.111828
Ciruelos EM, Rugo HS, Mayer IA, Levy C, Forget F, Delgado Mingorance JI, Safra T, Masuda N, Park YH, Juric D, Conte P, Campone M, Loibl S, Iwata H, Zhou X , Park J, Ridolfi A, Lorenzo I, Andre F. Patient-reported outcomes in patients with PIK3CA-mutated hormone receptor-positive, human epidermal growth factor receptor 2–negative advanced breast cancer from SOLAR-1 . J Clin Oncol. 2021 Jun 20;39(18):2005-15. doi: 10.1200/JCO.20.01139
Motzer RJ, Porta C, Alekseev B, Rha SY, Choueiri TK, Mendez-Vidal MJ, Hong SH, Kapoor A, Goh JC, Eto M, Wang J , Pan J, Ayele Asfaw A, He CS, Mody K, Cella D. Health-related quality-of-life (HRQoL) analysis from the phase 3 CLEAR trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) for patients (pts) with advanced renal cell carcinoma (aRCC) . Presented at the 2021 ASCO Conference; June 4, 2021. [abstract] J Clin Oncol. 2021; 39(Suppl 15):4502.
Wyrwicz L, Elimova E, Blum SI, Xiao H, Davenport E , Wang J , Hunter S, Li M, Kondo K, Mohler M. Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): interim results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649 . Poster presented at the 2021 ASCO Conference; June 4, 2021. [abstract] J Clin Oncol. 2021; 39(Suppl 15):4066. doi: 10.1200/JCO.2021.39.15_suppl.4066
Cella D, Hackshaw MD, Vondeling GT, Bennett L , Garbinsky D , Saito K, Sugihara M, Bang YJ, Yamaguchi K, Shitara K. Quality-adjusted time without symptoms or toxicity (Q-TWiST) of trastuzumab deruxtecan (T-DXd) versus chemotherapy in patients with advanced gastric cancer from the DESTINY-Gastric01 trial . Poster presented at the 2021 ASCO Conference; June 4, 2021. [abstract] J Clin Oncol. 2021; 39(Suppl 15):4057. doi: 10.1200/JCO.2021.39.15_suppl.4057
Thiesse L, Rudzik F, Kraemer JF, Spiegel K, Leproult R, Wessel N, Pieren R, Heritier H, Eze IC, Foraster M , Garbazza C, Vienneau D, Brink M, Wunderli JM, Probst-Hensch N, Roosli M, Cajochen C. Transportation noise impairs cardiovascular function without altering sleep: the importance of autonomic arousals . Environ Res. 2020 Mar;182:109086. doi: 10.1016/j.envres.2019.109086
Mortamais M, Pujol J, Martínez-Vilavella G, Fenoll R, Reynes C, Sabatier R, Rivas I, Forns J , Vilor-Tejedor N, Alemany S, Cirach M, Alvarez-Pedrerol M, Nieuwenhuijsen M, Sunyer J. Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children . Environ Res. 2019 Nov;178:108734. doi: 10.1016/j.envres.2019.108734
Fizazi K, Shore ND, Tammela T, Kuss I, Le Berre M, Mohamed AF, Odom D , Bartsch J , Snapir A, Sarapohja T, Smith MR. Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (PTS) with nonmetastatic castrate-resistant prostate cancer (NMCRPC) . Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting; May 31, 2019. Chicago, IL. [abstract] J Clin Oncol. 2019 Jun; 37(15_Suppl).
Kummar S, Mascarenhas L, Geoerger B, Turpin B, Cox, MC, Yu S, Nanda S, Hiemeyer F, Keating KN, Chirila C , Gnanasakthy A , Davenport E , Hong DS, Drilon AE. Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib . Poster presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2019. Chicago, IL. [abstract] J Clin Oncol. 2019 Jun; 37(2019):6602.
Price M , Ravelo A, Sae-Hau M, Torney PA, Gonzalez V, Weiss ES, Mansfield C , Mange B, Comenencia Ortiz E, Masaquel A, Lamont Dawson K. Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: results from a national patient advocacy survey . Poster presented at the 2019 ASCO Annual Meeting; May 2019. [abstract] J Clin Oncol. 2019 May 26; 37(15_suppl):e18198. doi: 10.1200/JCO.2019.37.15_suppl.e18198
Saif WM, Parikh R , Ray D, Kaye JA, Kurosky SK, Thomas K, Beveridge T, Mirakhur B, Lubeck CA, Nagar SP , Soares H. The sequencing of lanreotide (LAN) after octreotide LAR (OCT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) . Poster presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2018. Chicago, IL. [abstract] J Clin Oncol. 2018 Jun 1; 36(15_suppl):e16174. doi: 10.1200/JCO.2018.36.15_suppl.e16174
Winfree KB, Ainsworth C, Njue A , Molife C, Lyall M, Jen MH, Bittoni M, Heyes A , Carbone DP. Novel antiangiogenic drugs, immune checkpoint inhibitors, and chemotherapy in patients with aNSCLC who have aggressive disease: a systematic review . J Clin Oncol. 2018 May 16;36(15_suppl):e21120-e. doi: 10.1200/JCO.2018.36.15_suppl.e21120
Gascon M, Sanchez-Benavides G, Dadvand P, Martinez D , Gramunt N, Gotsens X, Cirach M, Vert C, Molinuevo JL, Crous-Bou M, Nieuwenhuijsen M. Long-term exposure to residential green and blue spaces and anxiety and depression in adults: a cross-sectional study . Environ Res. 2018 Apr;162:231-9. doi: 10.1016/j.envres.2018.01.012
Fernandez-Martos C, Pericay C, Losa F, Garcia-Carbonero R, Layos L, Rodriguez Salas N, Martin M, Alonso V, Vera R, Gallego J, Capdevila J, Salud A, Nogue M, Maurel J, Guasch I, Montagut Viladot C, Lopez-Lopez C, Canas MA, Declara IM, Garcia-Albeniz X . Randomized phase II study comparing induction (I) mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and total mesorectal excision (TME) in high risk-rectal cancer. GEMCAD 14-02 trial . Poster presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting; June 3, 2018. Chicago, IL. [abstract] J Clin Oncol. 2018; 36(2018):e3518.